Registry for inflammatory bowel disease in southeastern Korea
Official title: Observational Study Using Inflammatory Bowel Disease Registry in Daegu-Gyeongbuk, Southeastern Area of Korea
Run by Kyungpook National University Hospital · NCT02193464 · Data updated 2026-11-12
This study is collecting information from patients with Crohn's disease and ulcerative colitis in southeastern Korea to see how these conditions develop and change over time.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Kyungpook National University Hospital Academic / other |
| Locations | 1 site (Daegu) |
| Status | Recruiting |
| Started | September 2014 |
| Main results expected | December 2025 |
| Study ends | December 2026 |
| Registry record updated | January 12, 2021 |
| Trial ID | NCT02193464 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals diagnosed with inflammatory bowel disease who have been monitored for at least six months and reside in the Daegu-Gyeongbuk province.
✕Probably not a fit
Patients living outside the Daegu-Gyeongbuk province will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to investigate the incidence and natural progression of idiopathic chronic inflammatory bowel disease, including Crohn's disease and ulcerative colitis, in the Daegu-Gyeongbuk region of Korea. By collecting data from patients diagnosed with these conditions and followed for at least six months, the study seeks to provide insights into the disease's characteristics and trends in this specific geographic area. The findings may help improve understanding and management of inflammatory bowel disease in the region.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of inflammatory bowel disease, leading to better diagnosis and treatment strategies for patients.
How similar studies have gone: While similar registries have been established in other regions, this specific study is novel in its focus on the southeastern area of Korea.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Clinical diagnosis of inflammatory bowel disease including Crohn's disease and ulcerative colitis * Followed up for at least 6 months for the correct diagnosis Exclusion Criteria: * Patients who do not live in Daegu-Gyeongbuk province
Where it's running
-
Keimyung University Dongsan Medical Center
Daegu, South Korea Recruiting
Study contacts
- Principal investigator: Eun Soo Kim, MD, PhD — Keimyung University School of Medicine
- Study coordinator: Eun Soo Kim, MD. PhD
- Email: dandy813@hanmail.net
- Phone: +82-53-250-7088
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluating treatment for asymptomatic common bile duct stones
This study is testing how well treating asymptomatic common bile duct stones works compared to not treating them at all, to help doctors decide the best way to manage these cases.
-
Analyzing eye fluid biomarkers in patients with retinal diseases
This study is trying to see if certain eye fluids can help us understand how serious retinal diseases like diabetic retinopathy and age-related macular degeneration are in patients.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.